Overview:

The rise of new diseases and infections has led to the need for accelerated development of safe and effective vaccines. In addition, the search for vaccines continues for long-known pandemic diseases such as HIV and Malaria, since currently no effective vaccines to battle these diseases, exist.
Join this webinar to learn more on novel chromatography solutions which can help in improving the downstream processes of different vaccine types such as mRNA, recombinant proteins and Virus Like Particles (VLPs). In addition, we will demonstrate solutions to address regulatory requirements for safety and purity testing throughout the vaccine production process and discuss the benefits of implementing automated systems to save time and demonstrate product quality and safety.